Educational CME Accredited Programme

The Omega-3 tale: where do we stand?

EAS have independently organised all matters related to this 90-minute programme, including content and presenters. We acknowledge financial support, in the form of an educational grant, received from industry in support of the programme.


New approaches to LDL lowering

EAS have independently organised all matters related to this 90-minute programme, including content and presenters. We acknowledge financial support, in the form of an educational grant, received from industry in support of the programme.


PCSK9 inhibition: new insights from clinical trials

EAS have independently organised all matters related to this 90-minute programme, including content and presenters. We acknowledge financial support, in the form of an educational grant, received from industry in support of the programme.


Moving from high-intensity statin therapy to high-intensity lipid lowering therapy. Is it time to reconsider the guidelines?

EAS have independently organised all matters related to this 90-minute programme, including content and presenters. We acknowledge financial support, in the form of an educational grant, received from industry in support of the programme.


Problems and solutions in lipid lowering therapy: how to optimise dyslipidaemia management

EAS have independently organised all matters related to this 90-minute programme, including content and presenters. We acknowledge financial support, in the form of an educational grant, received from industry in support of the programme.


How can we improve outcomes in our patients with CAD?

EAS have independently organised all matters related to this 90-minute programme, including content and presenters. We acknowledge financial support, in the form of an educational grant, received from industry in support of the programme.